NDC 0517-2502-01 - Caffeine and Sodium Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0517-2502
- Requested NDC
- 0517-2502-01
- Package NDCs from labels
- 0517-2502-01, 0517-2502-10
- Manufacturer
- American Regent, Inc.
- Effective date
- 2019-12-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CAFFEINE AND SODIUM BENZOATE INJECTION, USP | American Regent, Inc. | 2019-12-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0517-2502-01 | Caffeine and Sodium Benzoate | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 7 | |
| 0517-2502-10 | Caffeine and Sodium Benzoate | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0517-2502-01 | ML - Milliliter | 0517-2502 | d7f8e535-ca10-4ba1-a0b6-b855c1d92936 | 1 | 2019-04-11 |
| 0517-2502-10 | ML - Milliliter | 0517-2502 | d29437c4-d880-4d96-8542-9b17a6fc2fc0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CAFFEINE | ACTIVE INGREDIENT | 3G6A5W338E | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| CAFFEINE | ACTIVE MOIETY | 3G6A5W338E | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eyesaline Emergency Eyewash | PURIFIED WATER | Protective Industrial Products, Inc. | 55a261c2-725d-6765-e063-6294a90a3260 | 2026-07-02 | Warnings | 059QF0KO0R |
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Salado Sales, Inc. | ca21d576-be3c-495d-9dbd-ed514bf65da7 | 2026-07-01 | Warnings | 3G6A5W338E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Wal-Mart Stores Inc | 9b1201af-c802-4e19-b192-bbbf34367db4 | 2026-06-30 | Warnings | 3G6A5W338E |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | United Natural Foods, Inc. dba UNFI | b6ff2b34-51ee-41bc-8b7d-7520ade0bf36 | 2026-06-30 | Warnings | 3G6A5W338E |
| MENSTRUAL COMPLETE | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Rite Aid Corporation | de723b85-011c-4014-82a8-e813460e3f12 | 2026-06-25 | Warnings | 3G6A5W338E |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37dead3e-60cb-88ae-e063-6294a90a8f70 | 2026-06-24 | Warnings | 059QF0KO0R |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | DOLGENCORP, LLC | e1e24d52-0b4d-400b-8181-e3f6ab75c4f6 | 2026-06-18 | Warnings | 3G6A5W338E |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| Stay Awake Maximum Strength | CAFFEINE | United Natural Foods, Inc. dba UNFI | 1357eade-f1d3-4df2-8a8a-4c318aab1141 | 2026-06-15 | Warnings | 3G6A5W338E |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5423bde6-3e31-38b0-e063-6294a90afb2d | 2026-06-13 | Warnings | QTT17582CB |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | P & L Development, LLC | 55e996cd-ef22-4e09-a05c-8aa994e4540b | 2026-06-12 | Warnings | 3G6A5W338E |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | BM Private Limited | 540d11e3-e4a1-0ca2-e063-6394a90a3c26 | 2026-06-12 | Warnings | QTT17582CB |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 54113d1f-e8e7-6b4c-e063-6394a90a0edf | 2026-06-12 | Warnings | 059QF0KO0R |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | BM Private Limited | 53fa21d9-1f80-2e69-e063-6394a90ab9f3 | 2026-06-11 | Warnings | 059QF0KO0R |
| Butalbital, Acetaminophen and Caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Preferred Pharmaceuticals Inc. | 65fa9aca-ef3d-4bc6-a107-72e6eb5ce224 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Stay Awake | CAFFEINE | Wal-Mart Stores Inc | 5f5b65a2-4db7-4c8e-a954-95611a087217 | 2026-06-08 | Warnings | 3G6A5W338E |
| XIMONTH Fungi Free Bee Venom Nail Soothing Serum | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 53bab969-8407-6334-e063-6294a90aa5d1 | 2026-06-08 | Warnings | 059QF0KO0R |
| Diurex Ultimate | CAFFEINE | Kobayashi Healthcare International, Inc. | c6debbfe-6061-463f-8f17-fb240c6f1bab | 2026-06-08 | Warnings | 3G6A5W338E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.